| Product Name | Goat anti-KMT2B/MLL4 Antibody |
|---|---|
| Synonyms | KMT2B; MLL4; myeloid/lymphoid or mixed-lineage leukemia 4; HRX2; MLL2; KIAA0304; KIAA0304 gene product; DYT28; MLL1B; WBP7; WBP-7; CXXC10; Lysine methyltransferase 2B histone-lysine N-methyltransferase 2B[ |
| Host | Goat |
| Clonality | Polyclonal |
| Conjugate | Unconjugated |
| Immunogen | CNCGAKRCRRFLN |
| Molecular Weight | 294 |
| Target | KMT2B/MLL4 |
| Amino Acid Sequence | CNCGAKRCRRFLN |
| Reactivity | Canine, Human, Mouse, Porcine, Rat |
| Applications | ELISA, IHC |
| Working Dilutions | Peptide ELISA: antibody detection limit dilution 1:128000. |
| Form | Liquid, in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin |
| Diluent Buffer | Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH 7.3 with 0.5% bovine serum albumin. Aliquot and store at -20°C. Minimize freezing and thawing. |
| Reconstitution | WB: Using our routine western blotting protocol we would not expect to reliably detect proteins larger than 250kDa (calculated MWt. of approx. 294KDa according to NP_055542.1).. IHC: Positive staining seen in paraffin embedded Human Testis and Human Brain Cortex. Recommended concentration: 5-10µg/ml. |
| Gene Id | Human GeneIDs: 9757. Non-Human GeneIDs: 75410 (mouse); |
| Storage | Aliquot and store at -20°C. Minimize freezing and thawing. |
| References | Huntsman DG, Chin SF, Muleris M, Batley SJ, Collins VP, Wiedemann LM, Aparicio S, Caldas C. , MLL2, the second human homolog of the Drosophila trithorax gene, maps to 19q13.1 and is amplified in solid tumor cell lines., Oncogene. 1999 Dec 23;18(56):7975-84., PMID: 10637508 |
| Supplier | Everest Biotech |
All Research Products are sold for laboratory RESEARCH USE ONLY and ARE NOT TO BE USED FOR HUMAN OR ANIMAL THERAPEUTIC OR DIAGNOSTIC APPLICATIONS. The information presented is believed to be accurate; however, said information and products are offered without warranty or guarantee since the ultimate conditions of use and the variability of the materials treated are beyond our control. Nothing disclosed herein is to be construed as a recommendation to use our products in violation of any patents. ARP American Research Products, Inc. does not submit its products for regulatory review by any government body or other organization, and we do not validate them for clinical, therapeutic or diagnostic use, or for safety and effectiveness. You are solely responsible for making sure that the way you use the products complies with applicable laws, regulations and governmental policies and for obtaining all necessary approvals, intellectual property rights, licenses and permissions that you may need related to your use. Under no circumstances shall ARP American Research Products, Inc. be liable for damages, whether consequential, compensatory, incidental or special, strict liability or negligence, breach of warranty or any other theory arising out of the use of the products available from ARP American Research Products, Inc. Nothing contained herein warrants that the use of the products will not infringe on the claims of any patents covering the product itself or the use thereof in combination with other products or in the operation of any process. ARP American Research Products, Inc. disclaims any and all representations or warranties of any kind whatsoever, express or implied, including without limitation any implied warranties of merchantability or fitness for a particular purpose, of non-infringement, or regarding results obtained through the use of any product, whether arising from a statute or otherwise in law or from a course of performance, dealing or usage of trade.
